Importantly, studies have demonstrated that TP is overexpressed in human tumors, including those associated with non-small cell lung cancer (NSCLC), with TP expression level shown to be positively correlated with advanced-stage tumor metastasis and poor prognosis (26, 27). Here, TYMP is linked to non-small cell lung carcinoma.